Takeda Pharmaceutical Co., Ltd. (TAK)
16.16
-0.17
(-1.04%)
USD |
NYSE |
Jan 16, 16:00
16.16
0.00 (0.00%)
Pre-Market: 20:00
Takeda Pharmaceutical Market Cap: 51.04B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 276.96B |
| Pfizer Inc. | 145.84B |
| Sanofi | 113.63B |
| Nxera Pharma Co., Ltd. | 516.73M |
| Protagonist Therapeutics, Inc. | 5.126B |
Market Cap Related Metrics
| PE Ratio | 205.08 |
| PS Ratio | 1.740 |
| Price to Book Value | 1.057 |
| Price to Free Cash Flow | 9.349 |
| Price | 16.16 |
| Earnings Yield | 0.49% |
| Operating PE Ratio | 15.73 |
| Normalized PE Ratio | 86.60 |